DTx Pharma

Please note: The information displayed on this page might be outdated.
DTx Pharma: Developer of an RNA-based therapeutics designed to aid in personalized treatment across most therapeutic areas. The company's technology enables efficient delivery of nucleic acid drugs to tissues throughout the body, enabling healthcare providers to deliver oligos in vivo at therapeutically relevant doses that work in many cell types including neurons, endothelial and T cells.
Based in...
US - Pacific
3210 Merryfield Row
San Diego, CA 92121
United States

Company Participants at Fall Private Company Showcase 2020

Arthur Suckow
DTx Pharma, CEO
Dr. Suckow received his PhD from University of California, San Diego and has worked for Johnson & Johnson, AstraZeneca, where he co-founded and managed the biologics laboratory of over 30 scientists, and Regulus Therapeutics. Dr. Suckow’s extensive experience in lipid pharmacology includes advancing lipidated peptides into clinical development and taking small molecules targeting lipid receptors into clinical development.

Upcoming Company Event Participation